About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Efficacy of Selegiline in Negative Symptoms of Schizophrenia

NCT00456976·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Tabriz University

Age

20–65

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Patients with moderate to severe negative symptoms
Patients with at least one year antipsychotic drug therapy, at the current dose \>= 1 month.
No other psychotropic drugs during past month

You may not be if

Severe major depressive disorder
Substance abuse
Severe positive symptoms of schizophrenia
Treatment of MDD with antidepressant drugs during past month.

The record

StatusCompleted

PhaseEarly phase 1

Taking part70

StartedApr 2007

UpdatedJul 23, 2008

Conditions

Where1

Razi university hospital
Tabriz, East Azerbaijan Province, Iran

Clareo Health | Efficacy of Selegiline in Negative Symptoms of Schizophrenia